Pencil-beam scanning proton therapy for anal cancer: a dosimetric comparison with intensity-modulated radiotherapy (Q41312134)

29 September 2017

Pencil-beam scanning proton therapy for anal cancer: a dosimetric comparison with intensity-modulated radiotherapy (English)

1 reference

29 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25734796%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Reid F Thompson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25734796%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

John P Plastaras

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25734796%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Maura L Kirk

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25734796%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Huifang Zhai

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25734796%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

James M Metz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25734796%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Stefan Both

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25734796%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Edgar Ben-Josef

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25734796%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

publication date

3 March 2015

1 reference

29 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25734796%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25734796%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

1209-1217

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25734796%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25734796%20AND%20SRC:MED&resulttype=core&format=json

Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11.

4 June 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.1002570

Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.1002570

Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.1002570

RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.1002570

Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.1002570

Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.1002570

Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.1002570

Integrated peripheral boost in preoperative radiotherapy for the locally most advanced non-resectable rectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.1002570

Irradiation with protons for the individualized treatment of patients with locally advanced rectal cancer: a planning study with clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.1002570

Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.1002570

Normal tissue complication probability modeling of acute hematologic toxicity in patients treated with intensity-modulated radiation therapy for squamous cell carcinoma of the anal canal.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.1002570

Lumbosacral spine and marrow cavity modeling of acute hematologic toxicity in patients treated with intensity modulated radiation therapy for squamous cell carcinoma of the anal canal

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.1002570

The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.1002570

Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: investigating dose-volume relationships and role for inverse planning.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.1002570

The dose-volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.1002570

Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.1002570

Long-term quality of life after radiotherapy for the treatment of anal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.1002570

Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.1002570

Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.1002570

Dose-volume effects for normal tissues in external radiotherapy: pelvis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.1002570

RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.1002570

Radiation dose-volume effects of the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.1002570

The relationship between external beam radiotherapy dose and chronic urinary dysfunction--a methodological critique

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.1002570

Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.1002570

Interstitial high-dose rate brachytherapy as boost for anal canal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.1002570